China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
Clinical trial NCT04974151 · RECRUITING
Trial details
- NCT number
- NCT04974151
- Sponsor
- Shenzhen Ausa Pharmed Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-22
- Primary completion
- 2029-06-30
- Enrollment
- 24000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.